News and Updates

In order to bring greater awareness to the issue of Post-Traumatic Stress Disorder (PTSD), the United States Senate designated June 27th as National PTSD Awareness Day. Here are a few things you need to know about PTSD and warning signs to look for in your own life or the life of a loved one. PTSD… Read On »

Drew Rothermel, MBA, JD – President and Chief Executive Officer With the opioid crisis now at epidemic proportions, the need to deliver superior substance use disorder treatment has become profoundly important. Desperate for a solution, thousands of struggling patients and their families are finding themselves entangled in the broken system recently highlighted in the New… Read On »

The FDA recently asked Endo Pharmaceuticals to pull its opioid pain medication, Opana ER, from the market citing concerns that the drug’s benefits may no longer outweigh its risks.   This is the first time the agency has taken action to stop the sale of an opioid pain medication based on the public health consequences… Read On »

Over a decade’s worth of research recently confirmed that teens who attended high-achieving schools in affluent communities showed a greater vulnerability to drug and alcohol misuse than their peers.   This study, released last week in Development and Psychopathology, bolsters previous studies in this area and reaffirms the industry-wide experience of thousands of addiction professionals. “Like… Read On »

In recent news, the state of Ohio filed a suit against five drug companies, accusing them of fueling the opioid crisis by misleading prescribing doctors about the risks of addiction associated with opioid medication. Ohio is the second state to sue opioid manufacturers, with a suit from Mississippi coming earlier this year. “The opioid addiction… Read On »

by Vice President of Clinical Operations, Kerry Coyle, MSW In a shocking news report released yesterday, two staffers were found dead after having overdosed on heroin and fentanyl in an unlicensed Pennsylvania recovery home. The tragic story highlights the critical nature of the opioid epidemic in the United States while drawing attention to systemic concerns about the clinical integrity… Read On »

Brad Sylvain, MPA, CAP – Executive Director Brad brings nearly a decade of mental health and substance use disorder treatment experience to his role as Executive Director of Hanley Center. As the former Corporate Director of Admissions, he was responsible for most appropriately placing patients in treatment programs, either within the Origins’ continuum or with… Read On »

by Dr. Frank Lawlis, Director of Psychological and Neurological Plasticity Programs     Since its inception, The PsychoNeuroPlasticity Center (PNP) inside of Origins has focused highly on combating addiction through on cutting-edge research on the brain’s capacity to restructure and renew itself.  Those of us within the PNP Center are very pleased with the direction and potentials… Read On »

Connie Motley – Clinical Director, Hanley Center at Origins In her new role as Clinical Director, Connie will provide clinical leadership and administrative oversight to the substance use disorder treatment programs at Hanley Center. Having previously spent five years at Origins in South Padre Island, Connie is well versed in Origins’ treatment modalities and its… Read On »

WEST PALM BEACH, Fla. (May 9, 2017) – Origins Behavioral HealthCare today announced it has been acquired by TRT Holdings, Inc., a diversified private holding company owned by the Rowling family of Dallas that owns other successful brands, including Omni Hotels & Resorts and Gold’s Gym. This major acquisition in the substance use disorder treatment… Read On »